The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review
Open accessAbstract
Alzheimer’s disease is one of the most commonly diagnosed cases of senile dementia in the world. It is an incurable process, most often leading to death. This disease is multifactorial, and one factor of this is inflammation. Numerous mediators secreted by inflammatory cells can cause neuronal degeneration. Neuritis may coexist with other mechanisms of Alzheimer’s disease, contributing to disease progression, and may also directly underlie AD. Although much has been established about the inflammatory processes in the pathogenesis of AD, many aspects remain unexplained. The work is devoted in particular to the pathomechanism of inflammation and its role in diagnosis and treatment. An in-depth and detailed understanding of the pathomechanism of neuroinflammation in Alzheimer’s disease may help in the development of diagnostic methods for early diagnosis and may contribute to the development of new therapeutic strategies for the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806
Sies, H., Berndt, C., & Jones, D. P. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045037 · Cited by 3,520
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Breijyeh, Z., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25245789 · Cited by 2,789
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
Inflammation as a central mechanism in Alzheimer's disease
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253 · cited 1×
“However, it is worth tracing the genesis of the neuroinflammation process [69,70] (Figure 1).”
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
Hampel, H., Mesulam, M.-M., Cuello, A. C., Farlow, M. R., Giacobini, E., Grossberg, G. T., Khachaturian, A. S., Vergallo, A., Cavedo, E., Snyder, P. J., et al. (2018) · Brain · doi:10.1093/brain/awy132 · Cited by 1,918
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261
Li, Q., Cheng, Z., Zhou, L., Darmanis, S., Neff, N. F., Okamoto, J., Gulati, G., Bennett, M. L., Sun, L. O., Clarke, L. E., et al. (2019) · Neuron · doi:10.1016/j.neuron.2018.12.006 · Cited by 1,129
Cytokines: From Clinical Significance to Quantification
Liu, C., Chu, D., Kalantar‐Zadeh, K., George, J., Young, H. A., & Liu, G. (2021) · Advanced Science · doi:10.1002/advs.202004433 · Cited by 940
Brain atrophy in Alzheimer’s Disease and aging
Pini, L., Pievani, M., Bocchetta, M., Altomare, D., Bosco, P., Cavedo, E., Galluzzi, S., Marizzoni, M., & Frisoni, G. B. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.002 · Cited by 836
The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention
Zhang, X.-X., Tian, Y., Wang, Z.-T., Ma, Y.-H., Tan, L., & Yu, J.-T. (2021) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2021.15 · Cited by 789
The Semantics of Microglia Activation: Neuroinflammation, Homeostasis, and Stress
Woodburn, S. C., Bollinger, J. L., & Wohleb, E. S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02309-6 · Cited by 783
Inflammatory processes in Alzheimer's disease
Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
Moussa, C., Hebron, M., Huang, X., Ahn, J., Rissman, R. A., Aisen, P. S., & Turner, R. S. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0779-0 · Cited by 705
Imaging the evolution and pathophysiology of Alzheimer disease
Jagust, W. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0067-3 · Cited by 604
Implications of sleep disturbance and inflammation for Alzheimer's disease dementia
Irwin, M. R., & Vitiello, M. V. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30450-2 · Cited by 578
Inflammatory Response in the CNS: Friend or Foe?
Sochocka, M., Diniz, B. S., & Leszek, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0297-1 · Cited by 573
Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease
Newcombe, E. A., Camats-Perna, J., Silva, M. L., Valmas, N., Huat, T. J., & Medeiros, R. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1313-3 · Cited by 532
Long, H.-Z., Cheng, Y., Zhou, Z.-W., Luo, H.-Y., Wen, D.-D., & Gao, L.-C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.648636 · Cited by 489
Alzheimer’s disease and its treatment by different approaches: A review
Srivastava, S., Ahmad, R., & Khare, S. K. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113320 · Cited by 467
Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
(2018) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.05.006 · Cited by 455
Economic burden of Alzheimer disease and managed care considerations
(2020) · The American Journal of Managed Care · doi:10.37765/ajmc.2020.88482 · Cited by 398
Dhapola, R., Hota, S. S., Sarma, P., Bhattacharyya, A., Medhi, B., & Reddy, D. H. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00889-6 · Cited by 383
Neuro-inflammation and anti-inflammatory treatment options for Alzheimer’s disease
Ozben, T., & Ozben, S. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.04.001 · Cited by 381
Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease
Mesulam, M. ‐. (2013) · Journal of Comparative Neurology · doi:10.1002/cne.23415 · Cited by 375
Webers, A., Heneka, M. T., & Gleeson, P. A. (2020) · Immunology & Cell Biology · doi:10.1111/imcb.12301 · Cited by 367
Inflammation in Alzheimer’s disease: Lessons learned from microglia-depletion models
Spangenberg, E. E., & Green, K. N. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.07.003 · Cited by 352
Salminen, A., Ojala, J., Kauppinen, A., Kaarniranta, K., & Suuronen, T. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.001 · Cited by 346
Song, T., Song, X., Zhu, C., Patrick, R., Skurla, M., Santangelo, I., Green, M., Harper, D., Ren, B., Forester, B. P., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101503 · Cited by 346
APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia
Sienski, G., Narayan, P., Bonner, J. M., Kory, N., Boland, S., Arczewska, A. A., Ralvenius, W. T., Akay, L., Lockshin, E., He, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz4564 · Cited by 336
Liao, H., Ye, J., Gao, L., & Liu, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110917 · Cited by 333
Neuroinflammation in Alzheimer’s Disease
Onyango, I. G., Jauregui, G. V., Čarná, M., Bennett, J. P., & Stokin, G. B. (2021) · Biomedicines · doi:10.3390/biomedicines9050524 · Cited by 330
Astrocytic interleukin-3 programs microglia and limits Alzheimer’s disease
McAlpine, C. S., Park, J., Griciuc, A., Kim, E., Choi, S. H., Iwamoto, Y., Kiss, M. G., Christie, K. A., Vinegoni, C., Poller, W. C., et al. (2021) · Nature · doi:10.1038/s41586-021-03734-6 · Cited by 322
Bennett, R. E., Robbins, A. B., Hu, M., Cao, X., Betensky, R. A., Clark, T., Das, S., & Hyman, B. T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710329115 · Cited by 299
IL-12 Family Cytokines in Cancer and Immunotherapy
Mirlekar, B., & Pylayeva-Gupta, Y. (2021) · Cancers · doi:10.3390/cancers13020167 · Cited by 295
dos Santos Picanco, L. C., Ozela, P. F., de Fatima de Brito Brito, M., Pinheiro, A. A., Padilha, E. C., Braga, F. S., de Paula da Silva, C. H. T., dos Santos, C. B. R., Rosa, J. M. C., & da Silva Hage-Melim, L. I. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867323666161213101126 · Cited by 284
Oxidative stress in alzheimer’s disease: A review on emergent natural polyphenolic therapeutics
Cassidy, L., Fernandez, F., Johnson, J. B., Naiker, M., Owoola, A. G., & Broszczak, D. A. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102294 · Cited by 275
Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance
Tuomisto, A. E., Mäkinen, M. J., & Väyrynen, J. P. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i31.4383 · Cited by 271
Neuroinflammation in mild cognitive impairment and Alzheimer’s disease: A meta-analysis
Bradburn, S., Murgatroyd, C., & Ray, N. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.01.002 · Cited by 268
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Song, C., Shi, J., Zhang, P., Zhang, Y., Xu, J., Zhao, L., Zhang, R., Wang, H., & Chen, H. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00292-3 · Cited by 266
Understanding the Role of Systemic Inflammation in Alzheimer’s Disease
Walker, K. A., Ficek, B. N., & Westbrook, R. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00333 · Cited by 259
Markowicz-Piasecka, M., Sikora, J., Szydłowska, A., Skupień, A., Mikiciuk-Olasik, E., & Huttunen, K. M. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2199-y · Cited by 257
Alzheimer’s-Causing Mutations Shift Aβ Length by Destabilizing γ-Secretase-Aβn Interactions
Szaruga, M., Munteanu, B., Lismont, S., Veugelen, S., Horré, K., Mercken, M., Saido, T. C., Ryan, N. S., De Vos, T., Savvides, S. N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.004 · Cited by 248
Microglia-neuron crosstalk: Signaling mechanism and control of synaptic transmission
Marinelli, S., Basilico, B., Marrone, M. C., & Ragozzino, D. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.05.017 · Cited by 233 · cited 2×
“There is a theory that β-amyloid itself induces the inflammatory process due to its accu ulation in the brain and the ability to bind the C1 component of the complement system, inducing neuroinflammation [71].”
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Ardura-Fabregat, A., Boddeke, E. W. G. M., Boza-Serrano, A., Brioschi, S., Castro-Gomez, S., Ceyzériat, K., Dansokho, C., Dierkes, T., Gelders, G., Heneka, M. T., et al. (2017) · CNS Drugs · doi:10.1007/s40263-017-0483-3 · Cited by 233
The Role of Selected Pro-Inflammatory Cytokines in Pathogenesis of Ischemic Stroke
Pawluk, H., Woźniak, A., Grześk, G., Kołodziejska, R., Kozakiewicz, M., Kopkowska, E., Grzechowiak, E., & Kozera, G. (2020) · Clinical Interventions in Aging · doi:10.2147/cia.s233909 · Cited by 218
Hou, J.-T., Yu, K.-K., Sunwoo, K., Kim, W. Y., Koo, S., Wang, J., Ren, W. X., Wang, S., Yu, X.-Q., & Kim, J. S. (2020) · Chem · doi:10.1016/j.chempr.2019.12.005 · Cited by 208
Kałużna, A., Olczyk, P., & Komosińska-Vassev, K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020400 · Cited by 208
Isik, A. T., Soysal, P., Solmi, M., & Veronese, N. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4965 · Cited by 201
Peripheral inflammatory biomarkers in Alzheimer’s disease: a brief review
Park, J.-C., Han, S.-H., & Mook-Jung, I. (2020) · BMB Reports · doi:10.5483/bmbrep.2020.53.1.309 · Cited by 201
Single-cell analyses of aging, inflammation and senescence
Uyar, B., Palmer, D., Kowald, A., Murua Escobar, H., Barrantes, I., Möller, S., Akalin, A., & Fuellen, G. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101156 · Cited by 200
Liu, J., Li, H., Gong, T., Chen, W., Mao, S., Kong, Y., Yu, J., & Sun, J. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c02807 · Cited by 199
Alzheimer’s Disease, Oligomers, and Inflammation
Forloni, G., & Balducci, C. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170819 · Cited by 194
Neuroinflammation and neurogenesis in Alzheimer's disease and potential therapeutic approaches
Sung, P.-S., Lin, P.-Y., Liu, C.-H., Su, H.-C., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030701 · Cited by 193
β-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia
Friker, L. L., Scheiblich, H., Hochheiser, I. V., Brinkschulte, R., Riedel, D., Latz, E., Geyer, M., & Heneka, M. T. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.025 · Cited by 191
Ahmad, M. H., Fatima, M., & Mondal, A. C. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.10.034 · Cited by 191
Albertini, C., Salerno, A., de Sena Murteira Pinheiro, P., & Bolognesi, M. L. (2021) · Medicinal Research Reviews · doi:10.1002/med.21699 · Cited by 179
Tacnet‐Delorme, P., Chevallier, S., & Arlaud, G. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6374 · Cited by 178
Amyloid‐β immunotherapy for alzheimer disease: Is it now a long shot?
Panza, F., Lozupone, M., Seripa, D., & Imbimbo, B. P. (2019) · Annals of Neurology · doi:10.1002/ana.25410 · Cited by 178 · cited 1×
“Currently, AD immunotherapy has been approved for phase I/II clinical trials [185].”
Astrocytes in Alzheimer's disease: pathological significance and molecular pathways
Preman, P., Alfonso-Triguero, M., Alberdi, E., Verkhratsky, A., & Arranz, A. M. (2021) · Cells · doi:10.3390/cells10030540 · Cited by 176
Astrocytes in Alzheimer´s Disease: Pathological Significance and Molecular Pathways
Preman, P., Alfonso-Triguero, M., Alberdi, E., Verkhratsky, A., & Arranz, A. M. (2021) · doi:10.20944/preprints202102.0230.v1 · Cited by 176
Biomarkers of inflammation and the etiology of sepsis
Grondman, I., Pîrvu, A., Riza, A. L., Ioana, M. I., & Netea, M. G. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190029 · Cited by 172
Wang, J., Song, Y., Zheng, C., & Leng, S. X. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1972714 · Cited by 168
Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
Correale, J., Marrodan, M., & Ysrraelit, M. C. (2019) · Biomedicines · doi:10.3390/biomedicines7010014 · Cited by 167
Epidemiology of neurological diseases in older adults
Dumurgier, J., & Tzourio, C. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.01.356 · Cited by 167
Glial cells in Alzheimer’s disease: From neuropathological changes to therapeutic implications
Uddin, M. S., & Lim, L. W. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101622 · Cited by 167
Acute phase reactant serum amyloid A in inflammation and other diseases
(2019) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2019.01.002 · Cited by 166
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Gowda, P., Reddy, P. H., & Kumar, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101529 · Cited by 163
Genetics of Alzheimer’s Disease
Vilatela, M. E. A., López, M., & Yescas, P. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.017 · Cited by 161
Zhu, L., Zhong, M., Elder, G. A., Sano, M., Holtzman, D. M., Gandy, S., Cardozo, C., Haroutunian, V., Robakis, N. K., & Cai, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510011112 · Cited by 160
The Toxicity and Polymorphism of β-Amyloid Oligomers
Huang, Y.-R., & Liu, R.-T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124477 · Cited by 159
Donoso, F., Cryan, J. F., Olavarría‐Ramírez, L., Nolan, Y. M., & Clarke, G. A. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2581 · Cited by 159
Custodero, C., Mankowski, R. T., Lee, S. A., Chen, Z., Wu, S., Manini, T. M., Hincapie Echeverri, J., Sabbà, C., Beavers, D. P., Cauley, J. A., et al. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.05.004 · Cited by 158
Lebois, E. P., Thorn, C. A., Edgerton, J. R., Popiolek, M., & Xi, S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.018 · Cited by 157
The Role and Therapeutic Targeting of α-, β- and γ-Secretase in Alzheimer's Disease
MacLeod, R., Hillert, E., Cameron, R. T., & Baillie, G. S. (2015) · Future Science OA · doi:10.4155/fso.15.9 · Cited by 149
Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
Nizami, S., Hall‐Roberts, H., Warrier, S., Cowley, S. A., & Di Daniel, E. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14618 · Cited by 147
CSF Cytokines in Aging, Multiple Sclerosis, and Dementia
Hu, W. T., Howell, J. C., Ozturk, T. T., Gangishetti, U., Kollhoff, A. L., Hatcher-Martin, J. M., Anderson, A. M. L., & Tyor, W. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00480 · Cited by 147
Pathophysiology and management of alzheimer’s disease: an overview
Thakur, A. K., Kamboj, P., Goswami, K., & Ahuja, K. (2018) · Journal of Analytical & Pharmaceutical Research · doi:10.15406/japlr.2018.07.00230 · Cited by 144
Fu, W., Wang, X., & Ip, N. Y. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00402 · Cited by 143
A lzheimer's disease and chronic periodontitis: Is there an association?
Gaur, S., & Agnihotri, R. (2014) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12425 · Cited by 140
Inflammation and Anti-Inflammatory Strategies for Alzheimer’s Disease – A Mini-Review
McNaull, B. B. A., Todd, S., McGuinness, B., & Passmore, A. P. (2009) · Gerontology · doi:10.1159/000237873 · Cited by 135
The endocytic pathway in microglia during health, aging and Alzheimer’s disease
Solé-Domènech, S., Cruz, D. L., Capetillo-Zarate, E., & Maxfield, F. R. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.07.002 · Cited by 133
Jensen, C. S., Bahl, J. M. C., Østergaard, L. B., Høgh, P., Wermuth, L., Heslegrave, A., Zetterberg, H., Heegaard, N. H. H., Hasselbalch, S. G., & Simonsen, A. H. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.04.003 · Cited by 133
Song, C., Zhang, Y., & Dong, Y. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-59 · Cited by 132
Zhang, D., Li, Y., Heims-Waldron, D. A., Bezzerides, V. J., Guatimosim, S., Guo, Y., Gu, F., Zhou, P., Lin, Z., Ma, Q., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.311349 · Cited by 132
Teter, B., Morihara, T., Lim, G. P., Chu, T., Jones, M. R., Zuo, X., Paul, R. M., Frautschy, S. A., & Cole, G. M. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.02.015 · Cited by 130
Winston, C. N., Goetzl, E. J., Schwartz, J. B., Elahi, F. M., & Rissman, R. A. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.11.002 · Cited by 130
Developing Effective Alzheimer’s Disease Therapies: Clinical Experience and Future Directions
Elmaleh, D. R., Farlow, M. R., Conti, P. S., Tompkins, R. G., Kundakovic, L., & Tanzi, R. E. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190507 · Cited by 129 · cited 1×
“From a clinical point of view, the genetic diagnostics of inflammation that develops in the course of Alzheimer’s disease is also important [159].”
Stocker, M., van Herk, W., el Helou, S., Dutta, S., Schuerman, F. A. B. A., Groot, R. K. V. D. T.-D., Wieringa, J. W., Janota, J., van der Meer-Kappelle, L. H., Moonen, R. M. J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa876 · Cited by 127
Millington, C., Sonego, S., Karunaweera, N., Rangel, A., Aldrich-Wright, J. R., Campbell, I. L., Gyengési, E., & Münch, G. W. (2014) · BioMed Research International · doi:10.1155/2014/309129 · Cited by 126
Sorrenti, V., Contarini, G., Sut, S., Dall’Acqua, S., Confortin, F., Pagetta, A., Giusti, P., & Zusso, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00183 · Cited by 125
Leveraging preclinical models for the development of Alzheimer disease therapeutics
Scearce-Levie, K. A., Sanchez, P. E., & Lewcock, J. W. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0065-9 · Cited by 124
Role of Calcium Homeostasis in Alzheimer’s Disease
Ge, M., Zhang, J., Chen, S., Huang, Y., Chen, W., He, L., & Zhang, Y. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s350939 · Cited by 124 · cited 1×
“These compounds can stimulate Tau protein hyperphosphorylation and disrupt the calcium homeostasis of neuronal cell membranes, inducing the process of apoptosis in nerve cells [31].”
Veerhuis, R., Van Breemen, M. J., Hoozemans, J. J., Morbin, M., Ouladhadj, J., Tagliavini, F., & Eikelenboom, P. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0624-7 · Cited by 123
Alzheimer’s Disease, Inflammation, and the Role of Antioxidants
Sinyor, B., Mineo, J., & Ochner, C. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200171 · Cited by 120
Inflammation and Alzheimer’s Disease: Mechanisms and Therapeutic Implications by Natural Products
Rather, M. A., Khan, A., Alshahrani, S., Rashid, H., Qadri, M. M., Rashid, S., Alsaffar, R. M., Kamal, M. A., & Rehman, M. U. (2021) · Mediators of Inflammation · doi:10.1155/2021/9982954 · Cited by 120
Fišar, Z. (2022) · Biomolecules · doi:10.3390/biom12111676 · Cited by 120
Li, T., Lu, L., Pember, E., Li, X., Zhang, B., & Zhu, Z. (2022) · Cells · doi:10.3390/cells11121925 · Cited by 118
Leinonen, V., Koivisto, A. M., Savolainen, S., Rummukainen, J., Sutela, A., Vanninen, R. L., Jääskeläinen, J. E., Soininen, H. S., & Alafuzoff, I. I. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01195.x · Cited by 116
Zabel, M., Nackenoff, A., Kirsch, W. M., Harrison, F. E., Perry, G., & Schrag, M. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.016 · Cited by 115
Avila-Muñoz, E., & Arias, C. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.004 · Cited by 114
Jo, D., Arumugam, T. V., Woo, H., Park, J. S., Tang, S., Mughal, M. R., Hyun, D., Park, J.-H., Choi, Y., Gwon, A., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.003 · Cited by 111
Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110
Multiplex Immunofluorescence: A Powerful Tool in Cancer Immunotherapy
Sheng, W., Zhang, C., Mohiuddin, T. M., Al-Rawe, M., Zeppernick, F. A., Falcone, F. H., Meinhold-Heerlein, I. M., & Hussain, A. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043086 · Cited by 108
From development to dysfunction: Microglia and the complement cascade in CNS homeostasis
Zabel, M. K., & Kirsch, W. M. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.02.001 · Cited by 107
Nagata, K., Yamazaki, T., Takano, D., Maeda, T., Fujimaki, Y., Nakase, T., & Sato, Y. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.06.001 · Cited by 107
Toll-Like Receptor 4: A Promising Therapeutic Target for Alzheimer’s Disease
Wu, L., Xian, X., Xu, G., Tan, Z., Dong, F., Zhang, M., & Zhang, F. (2022) · Mediators of Inflammation · doi:10.1155/2022/7924199 · Cited by 107
Guan, P.-P., Cao, L., & Wang, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115900 · Cited by 105
Graber, M. L., Rusz, D., Jones, M. L., Farm-Franks, D., Jones, B., Gluck, J. C., Thomas, D. B., Gleason, K. T., Welte, K., Abfalter, J., et al. (2017) · Diagnosis · doi:10.1515/dx-2017-0022 · Cited by 103
Ou, W., Yang, J., Simanauskaite, J., Choi, M. K., Castellanos, D. M., Chang, R., Sun, J., Jagadeesan, N., Parfitt, K. D., Cribbs, D. H., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02332-7 · Cited by 103
Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein
Gómez, W., Morales, R., Maracaja‐Coutinho, V., Parra, V., & Nassif, M. (2020) · Aging · doi:10.18632/aging.102677 · Cited by 102
AGE–RAGE stress: a changing landscape in pathology and treatment of Alzheimer’s disease
Prasad, K. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-019-03553-4 · Cited by 101
Microglial activation occurs late during preclinical Alzheimer's disease
Streit, W. J., Braak, H., Del Tredici, K., Leyh, J., Lier, J., Khoshbouei, H., Eisenlöffel, C., Müller, W., & Bechmann, I. (2018) · Glia · doi:10.1002/glia.23510 · Cited by 98
Molecular Characteristics of Amyloid Precursor Protein (APP) and Its Effects in Cancer
Lee, H. N., Jeong, M. S., & Jang, S. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094999 · Cited by 96
Chen, S., Chen, Y., Li, Y., Chen, S., Tan, J., Ou, T., Gu, L., & Huang, Z. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.07.033 · Cited by 95
Denver, P., & McClean, P. L. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.238608 · Cited by 95
The Neurotoxic Role of Extracellular Tau Protein
Sebastián‐Serrano, Á., de Diego-García, L., & Díaz-Hernández, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040998 · Cited by 90
Liposome based drug delivery as a potential treatment option for Alzheimer’s disease
Shukla, S., & Hernandez, C. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.327328 · Cited by 88
Role of Calcium Homeostasis in Alzheimer’s Disease
Ge, M., Zhang, J., Chen, S., Huang, Y., Chen, W., He, L., & Zhang, Y. (2022) · Dove Medical Press (Taylor and Francis Group) · Cited by 86
Das, S., Li, Z., Noori, A., Hyman, B. T., & Serrano-Pozo, A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01898-y · Cited by 80
Kellar, D., Register, T. C., Lockhart, S. N., Aisen, P. S. S., Raman, R., Rissman, R. A., Brewer, J. B., & Craft, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-05165-3 · Cited by 80
The cytokines interleukin-6 and interferon-α induce distinct microglia phenotypes
West, P. K., McCorkindale, A. N., Guennewig, B., Ashhurst, T. M., Viengkhou, B., Hayashida, E., Jung, S. R., Butovsky, O., Campbell, I. L., & Hofer, M. J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02441-x · Cited by 80
Sharoar, M. G., Palko, S., Ge, Y., Saido, T. C., & Yan, R. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00464-1 · Cited by 78
Qin, C., Lu, Y., Wang, K., Bai, L., Shi, G., Huang, Y., & Li, Y. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00199-x · Cited by 76
Electrochemical immunosensors for the detection of cytokine tumor necrosis factor alpha: A review
Fılık, H., & Avan, A. A. (2020) · Talanta · doi:10.1016/j.talanta.2020.120758 · Cited by 75
Current Progress on Neuroinflammation-mediated Postoperative Cognitive Dysfunction: An Update
Peng, W., Lü, W., Jiang, X., Xiong, C., Chai, H., Cai, L., & Lan, Z. (2022) · Current Molecular Medicine · doi:10.2174/1566524023666221118140523 · Cited by 74
Total DNA Methylation Changes Reflect Random Oxidative DNA Damage in Gliomas
Barciszewska, A., Giel-Pietraszuk, M., Perrigue, P. M., & Naskręt-Barciszewska, M. Z. (2019) · Cells · doi:10.3390/cells8091065 · Cited by 73
Gupta, N., Shyamasundar, S., Patnala, R., Karthikeyan, A., Arumugam, T. V., Ling, E., & Dheen, S. T. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1515917 · Cited by 71
APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease
Giau, V. V., Bagyinszky, E., Youn, Y. C., An, S. S. A., & Kim, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194757 · Cited by 69
Imai, R., Hori, H., Itoh, M., Lin, M., Niwa, M., Ino, K., Ogawa, S., Ishida, M., Sekiguchi, A., Matsui, M., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.04.009 · Cited by 68
Wang, Y.-B., Li, X., Bing, Y., Zhang, Q., Fei-Tong, J., Minghong, W., Xiangxiang, Z., Le, K., Li, Y., Ping, S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04765-1 · Cited by 68
Can We Treat Neuroinflammation in Alzheimer’s Disease?
Sánchez‐Sarasúa, S., Fernández-Pérez, I., Espinosa‐Fernández, V., Sánchez‐Pérez, A. M., & Ledesma, J. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228751 · Cited by 67
Oxidative Stress in the Newborn Period: Useful Biomarkers in the Clinical Setting
Millán, I., Piñeiro-Ramos, J. D., Lara‐Cantón, I., Llorca, A. P., Torres-Cuevas, I., & Vento, M. (2018) · Antioxidants · doi:10.3390/antiox7120193 · Cited by 64
Overview of the blood biomarkers in Alzheimer's disease: Promises and challenges
Delaby, C., Hirtz, C., & Lehmann, S. (2022) · Revue Neurologique · doi:10.1016/j.neurol.2022.09.003 · Cited by 64
Yaseen, S., Demopulos, G., Dudler, T., Yabuki, M., Wood, C. L., Cummings, W. J., Tjoelker, L. W., Fujita, T., Sacks, S. H., Garred, P., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201601306r · Cited by 63
Hashem, M., Esmael, A., Nassar, A. K., & El-Sherif, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-81631-8 · Cited by 63
Tsatsanis, A., McCorkindale, A. N., Wong, B. X. W., Patrick, E., Ryan, T. M., Evans, R. W., Bush, A. I., Sutherland, G. T., Sivaprasadarao, A., Guennewig, B., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01248-1 · Cited by 61
Li, L., Wu, X., Zhao, X.-J., Xu, L., Pan, C., & Zhang, Z. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01744-1 · Cited by 59
Gatta, V., Mengod, G., Reale, M., & Tata, A. M. (2020) · Biomedicines · doi:10.3390/biomedicines8060153 · Cited by 58
Erskine, D., Taylor, J., Bakker, G., Brown, A., Tasker, T. C. G., & Nathan, P. J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.08.009 · Cited by 57
Terrill, S. E., Mohan, M. J., & Nichols, M. R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.08.001 · Cited by 56
Hathout, R. M., El-Ahmady, S. H., & Metwally, A. A. (2017) · Natural Product Research · doi:10.1080/14786419.2017.1385017 · Cited by 56
Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events
Asik, R. M., Suganthy, N., Aarifa, M. A., Kumar, A., Szigeti, K., Máthé, D., Gulyás, B. Z., Archunan, G., & Padmanabhan, P. (2021) · Biomedicines · doi:10.3390/biomedicines9091126 · Cited by 56
Haddick, P. C. G., Alzheimer’s Disease Genetic Consortium (ADGC), A. D. N. I. (., Larson, J. L., Rathore, N., Bhangale, T. R., Phung, Q. T., Srinivasan, K., Hansen, D. V., Lill, J. R., Pericak-Vance, M. A., et al. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-160524 · Cited by 55
Greenhough, B., Dwyer, A. C., Grenyer, R., Hodgetts, T. J., McLeod, C. M., & Lorimer, J. (2018) · Humanities and Social Sciences Communications · doi:10.1057/s41599-018-0196-3 · Cited by 55
Silymarin’s Inhibition and Treatment Effects for Alzheimer’s Disease
Guo, H. W., Cao, H., Cui, X., Zheng, W., Wang, S., Yu, J., & Chen, Z. (2019) · Molecules · doi:10.3390/molecules24091748 · Cited by 54
Nirogi, R. V. S., Jayarajan, P., Shinde, A. K., Mohammed, A. R., Ramalingayya, G. V., Benade, V. S., Goyal, V., Abraham, R., Jasti, V., & Cummings, J. L. (2023) · Biomolecules · doi:10.3390/biom13020309 · Cited by 54
Sequence and structure-based peptides as potent amyloid inhibitors: A review
Mitra, A., & Sarkar, N. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108614 · Cited by 51
Nazareth, L., John, J. A. S., Murtaza, M., & Ekberg, J. A. K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660259 · Cited by 50
Risk Factors for Alzheimer’s Disease: An Epidemiological Study
Janoutová, J., Kovaľová, M., Machaczka, O., Ambrož, P., Zatloukalová, A., Němček, K., & Janout, V. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210820124135 · Cited by 50
Sultzer, D. L., Lim, A. C., Gordon, H. L., Yarns, B. C., & Melrose, R. J. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00954-w · Cited by 50
Trends in nanoformulations for atopic dermatitis treatment
Campos, E. V. R., Proença, P. L. D. F., Doretto-Silva, L., Andrade‐Oliveira, V., Fraceto, L. F., & de Araújo, D. R. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1813107 · Cited by 49
Ren, S., Breuillaud, L., Yao, W., Yin, T., Norris, K. A., Zehntner, S. P., & D’Adamio, L. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.016395 · Cited by 47 · cited 1×
“As one of the pro-inflammatory cytokines, TNF-α plays a very important role in the initiation and maintenance of the process of neuroinflammation, as well as in the physiological processes of remembering and learning [196,197].”
Bashir, H., Bhat, S. A., Majid, S., Hamid, R., Koul, R. K., Rehman, M. U., Din, I., Bhat, J. A., Qadir, J., & Masood, A. (2020) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.34.5 · Cited by 47
Song, L., Qu, Y. Q., Tang, Y. P., Chen, X., Lo, H. H., Li, Q., Yun, Y. X., Wong, V. K. W., Zhang, R. L., Wang, H. M., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102637 · Cited by 46
The microglial lysosomal system in Alzheimer’s disease: Guardian against proteinopathy
Van Acker, Z. P., Perdok, A., Bretou, M., & Annaert, W. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101444 · Cited by 45
C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration
Molins, B., Romero‐Vázquez, S., Fuentes‐Prior, P., Adán, A., & Dick, A. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00808 · Cited by 44
Fibrillar Amyloid Plaque Formation Precedes Microglial Activation
Jung, C. K. E., Keppler, K., Steinbach, S., Blázquez‐Llorca, L., & Herms, J. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119768 · Cited by 43
Kretzschmar, G. C., Bumiller‐Bini, V., Filho, M. A. G., Zonta, Y. R., Yu, K. S. T., de Souza, R. L. R., Dias‐Melicio, L. A., & Boldt, A. B. W. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.630869 · Cited by 43
Automated voxel-by-voxel tissue classification for hippocampal segmentation: Methods and validation
Tangaro, S., Amoroso, N., Boccardi, M., Bruno, S., Chincarini, A., Ferraro, G., Frisoni, G. B., Maglietta, R., Redolfi, A., Rei, L., et al. (2014) · Physica Medica · doi:10.1016/j.ejmp.2014.06.044 · Cited by 41
Karle, A. C., Wrobel, M. B., Koepke, S., Gutknecht, M., Gottlieb, S., Christen, B., Rubic-Schneider, T., Pruimboom‐Brees, I., Leber, X. C., Scharenberg, M., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abq5241 · Cited by 40
Hommet, C., Mondon, K., Camus, V., Ribeiro, M. J., Beaufils, É., Arlicot, N., Corcia, P., Paccalin, M., Minier, F., Gosselin, T., et al. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000354363 · Cited by 39
Yamaguchi, T., Costabel, U., McDowell, A., Guzman, J., Uchida, K., Ohashi, K., & Eishi, Y. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10050983 · Cited by 39
Pluta, R. M., Furmaga-Jabłońska, W., Januszewski, S., & Czuczwar, S. J. (2022) · Nutrients · doi:10.3390/nu14020248 · Cited by 39
Zhang, L., Li, D., Cao, F., et al. (2017) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207320666171123201910 · Cited by 38
Jankovská, N., Olejár, T., & Matěj, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010007 · Cited by 37
Shi, L., Yu, X., Li, H., Wu, G.-S., & Luo, H. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112145 · Cited by 36
Niznik, J. D., Zhao, X., He, M., Aspinall, S. L., Hanlon, J. T., Nace, D. A., Thorpe, J. M., & Thorpe, C. T. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15985 · Cited by 35
Emerging insights into the role of albumin with plasma exchange in Alzheimer’s disease management
Costa, M., & Páez, A. (2021) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2021.103164 · Cited by 33
Mitochondrial nanomedicine: Subcellular organelle-specific delivery of molecular medicines
Milane, L. S., Dolare, S., Jahan, T., & Amiji, M. M. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102422 · Cited by 33
Cheng, M., Ye, C., Tian, C., Zhao, D., Li, H., Sun, Z., Miao, Y., Zhang, Q., Wang, J., & Dou, Y. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.03.004 · Cited by 33
Drug Discovery and Development Targeting Dementia
Zagórska, A., Czopek, A., Fryc, M., Jaromin, A., & Boyd, B. J. (2023) · Pharmaceuticals · doi:10.3390/ph16020151 · Cited by 32
Larsen, E. L., Poulsen, H. E., Michaelsen, C., Kjær, L. K., Lyngbæk, M. P. P., Andersen, E. S., Petersen-Bønding, C., Lemoine, C., Gillum, M. P., Jørgensen, N. R., et al. (2020) · Journal of Sports Sciences · doi:10.1080/02640414.2020.1770918 · Cited by 30
The Function of Transthyretin Complexes with Metallothionein in Alzheimer’s Disease
Zaręba, N., & Kepinská, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239003 · Cited by 30
Inflammation-Related Risk Loci in Genome-Wide Association Studies of Coronary Artery Disease
Mauersberger, C., Schunkert, H., & Sager, H. B. (2021) · Cells · doi:10.3390/cells10020440 · Cited by 30
Fuellen, G., Liesenfeld, O., Kowald, A., Barrantes, I., Bastian, M., Simm, A., Jansen, L., Tietz-Latza, A., Quandt, D., Franceschi, C., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101091 · Cited by 29
Thalidomide alleviates neuropathic pain through microglial IL-10/β-endorphin signaling pathway
Deng, M.-Y., Ahmad, K. A., Han, Q.-Q., Wang, Z., Shoaib, R. M., Li, X., & Wang, Y. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114727 · Cited by 29
Meyer, N., Brodowski, L., von Kaisenberg, C., Schröder‐Heurich, B., & von Versen‐Höynck, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189696 · Cited by 29
Wang, T., Wang, Z., Cao, J., Dong, Y., & Chen, Y. (2022) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_110_21 · Cited by 28
Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes
Valenza, M., Facchinetti, R., Menegoni, G., Steardo, L., & Scuderi, C. (2021) · Biomolecules · doi:10.3390/biom11040600 · Cited by 26
Rahman, M. M., Mim, S. A., Tumpa, M. A. A., Sarker, M. T., Ahmed, M., Alghamdi, B. S. A., Hafeez, A., Alexiou, A. T., Perveen, A., & Ashraf, G. M. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155962 · Cited by 26
Dementia associated with disorders of the basal ganglia
Vitanova, K. S., Stringer, K. M., Benítez, D. P., Brenton, J., & Cummings, D. M. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24508 · Cited by 25
Bayliak, M. M., Gospodaryov, D. V., & Lushchak, V. I. (2023) · BBA Advances · doi:10.1016/j.bbadva.2023.100077 · Cited by 25
Ugbaja, S. C., Sanusi, Z. K., Appiah‐Kubi, P., Lawal, M. M., & Kumalo, H. M. (2020) · Biophysical Chemistry · doi:10.1016/j.bpc.2020.106536 · Cited by 24
Deep Brain Stimulation in Alzheimer’s Disease: Targeting the Nucleus Basalis of Meynert
Chen, Y., Shu, K., & Kang, H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201141 · Cited by 24
The Role of Aldose Reductase in Beta-Amyloid-Induced Microglia Activation
Huang, Y.-K., Liu, C.-C., Wang, S., Cheng, H.-C., Meadows, C., & Chang, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315088 · Cited by 24
Rossi, A., Galla, L., Gomiero, C., Zentilin, L., Giacca, M., Giorgio, V., Calí, T., Pozzan, T., Greotti, E., & Pizzo, P. (2021) · Cells · doi:10.3390/cells10020204 · Cited by 22
Components of the Lectin Pathway of Complement in Solid Tumour Cancers
Cedzyński, M., & Świerzko, A. S. (2022) · Cancers · doi:10.3390/cancers14061543 · Cited by 22
Pathogenic cis p-tau levels in CSF reflects severity of traumatic brain injury
Sisakht, A. M., Ziarati, N. K., Jahanbakhshi, A., Shahpasand, K., Aghababaei, S., Ahmadvand, O., Azar, M., Fattahi, A., & Zamanzadeh, S. (2022) · Neurological Research · doi:10.1080/01616412.2021.2022921 · Cited by 21
y Aibar, M. D. M., Romero‐Aibar, J., & Calvo, J. (2022) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12179 · Cited by 21
Huang, J., Tao, Q., Ang, T. F. A., Farrell, J. J., Zhu, C., Wang, Y., Stein, T. D., Lunetta, K. L., Massaro, J. M., Mez, J., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02281-6 · Cited by 21
Temviriyanukul, P., Chansawhang, A., Karinchai, J., Phochantachinda, S., Buranasinsup, S., Inthachat, W., Pitchakarn, P., & Chantong, B. (2023) · Nutrients · doi:10.3390/nu15051098 · Cited by 21
Vilela, A. F. L., Cardoso, C. L., & Mateo, C. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.09.071 · Cited by 20
Dallé, E., Mabandla, M. V., & Daniels, W. M. U. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5756382 · Cited by 19
Martins, D. A., Lopes, J., SILVA, A. C. F. D., Morais, C. I., Vasconcelos, J. H. L., Lima, I., Carneiro, C. S., & Neves, E. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.01.017 · Cited by 19
Cited by
Pathogenesis, Animal Models, and Drug Discovery of Alzheimer’s Disease
Xia, Z.-D., Ma, R.-X., Wen, J.-F., Zhai, Y.-F., Wang, Y.-Q., Wang, F.-Y., Liu, D., Zhao, X.-L., Sun, B., Jia, P., et al. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-230326 · Cited by 19
Wei, Z., Pan, X., Cui, X., Zhang, J., Dai, X., Zeng, Y., & Chen, X. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1537388 · Cited by 7
Metadata
- Authors
- Twarowski, B., & Herbet, M.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-03-30
- Volume
- 24
- Issue
- 7
- Pages
- 6518
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4362508588
- Cited by
- 412
- References
- 218
- FWCI
- 34.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.